Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Lung Neoplasms and JAK1[original query] |
---|
Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer. Oncology letters 2017 Oct 14 (4): 3959-3966. Liu Dan, Huang Yi, Zhang Li, Liang Dong-Ni, Li |
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC. Biochemical and biophysical research communications 2020 5 527 (1): 305-310. Kim Dong Min, Kim Mi Jin, Moon Jai-Hee, Lee Eun Young, Hong Jun Ki, Lee Seul, Koh Dong-In, Ryu Yae Seong, Kim Seung Mi, Jung Soo-A, Shin Jae-Sik, Kim Joseph, Park Yoon Sun, Hong Seung-Woo, Lee So Hee, Jung Joonyee, Park Sang Soo, Kim Do Yeon, Kim Eun Ho, Jeong Hong-Rae, Gong Ji Hee, Kim Jieun, Chan Kim Seung, Yu Ha Na, Ki So Young, Kim Tae Won, Jin Dong-Ho |
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades. Frontiers in oncology 2021 6 11 650122. Wang Xiaoyan, Wu Bingchen, Yan Zhengqing, Wang Guoqiang, Chen Shiqing, Zeng Jian, Tao Feng, Xu Bichun, Ke Honggang, Li M |
A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer. Cancer chemotherapy and pharmacology 2021 11 89 (1): 105-115. Padda Sukhmani K, Reckamp Karen L, Koczywas Marianna, Neal Joel W, Kawashima Jun, Kong Shengchun, Huang Daniel B, Kowalski Mark, Wakelee Heather |
- Page last reviewed:Feb 1, 2024
- Content source: